New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
AIM ImmunoTech Inc. (AIM) vs Cardio Diagnostics Holdings, Inc. (CDIO)
- AIM ImmunoTech Inc. AIM 0.12 −7.69%
- Cardio Diagnostics Holdings, Inc. CDIO 1.65 −2.37%
AIM ImmunoTech Inc. and Cardio Diagnostics Holdings, Inc. are both Biotechnology companies. AIM ImmunoTech Inc. and Cardio Diagnostics Holdings, Inc. are of similar size ($4.9M and $4.8M). Cardio Diagnostics Holdings, Inc. grew revenue faster over the last twelve months: −3.16% against −18.8%. AIM ImmunoTech Inc. has the higher net margin (−15,526.4% vs −42,401.3%) and the lower return on invested capital (−5,687.5% vs −228.0%). Across the 16 metrics below, AIM ImmunoTech Inc. leads on 8 and Cardio Diagnostics Holdings, Inc. on 8.
Valuation
Profitability
| Metric | AIM | CDIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 38.46% | 100.00% | 70.18% |
| Operating margin | (12,800.00%) | (42,328.76%) | 0.00% |
| Net margin | (15,526.37%) | (42,401.31%) | 0.00% |
| Free cash flow margin | (13,792.31%) | (37,804.58%) | 0.00% |
| Return on equity | (2,828.63%) | (93.55%) | (51.58%) |
| Return on assets | (185.36%) | (87.24%) | (45.91%) |
| Return on invested capital | (5,687.50%) | (227.99%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack